Pharmafile Logo
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • - PMLiVE
  • Communiqué 53 Cover Image

OTC Awards

- PMLiVE

Supporting our team with an award-winning mental health strategy

Mental health has been at the centre of our business since our inception. But that work doesn't just extend to our client projects. Find out more about our award-winning mental...

Mednet

- PMLiVE

Pfizer announces phase 3 results for potential non-small cell lung cancer treatment

Patients who had received only one prior line of systemic therapy showed a stronger trend for overall survival and progression-free survival

- PMLiVE

The value: why localisation pays off across global trials

Strong localisation reduces trial friction, supports site teams, improves participant understanding and helps global studies run more smoothly, fairly and efficiently.

Cuttsy + Cuttsy

- PMLiVE

MRM Health appoints Hans-Jürgen Wörle as Independent Director

Wörle previously held senior roles at Nestlé Health Science and Boehringer Ingelheim

- PMLiVE

Gilead’s Trodelvy approved by EC as first-line treatment for metastatic triple-negative breast cancer

TNBC is the most aggressive type of breast cancer and has historically been difficult to treat

- PMLiVE

MRM Health appoints Michel Detheux as Chairman of the Board

Detheux was previously founding CEO of iTeos Therapeutics

- PMLiVE

Sanofi’s Cenrifki approved in Europe for secondary progressive MS without relapses

SPMS is a debilitating stage of MS where patients experience increasing levels of disability

- PMLiVE

Lundbeck appoints Tarek Samad as EVP, Head of Research & Development

Samad previously held senior research leadership positions at Immunitas Therapeutics, Sanofi and Pfizer

Genesis Research Group free access image

Genesis Research Group launches free access to EVID AI, its full-spectrum evidence synthesis platform, through 2026

Genesis Research Group today announced that its EVID AI evidence synthesis platform will be available free of charge through 2026 for approved life sciences organizations and eligible researchers. “Run it...

Genesis Research Group

- PMLiVE

Medscape Education to Showcase the Impact of Neurology CME at EAN 2026

Medscape Education, the leading global provider of continuing medical education (CME), has announced its agenda for the upcoming 12th Congress of the European Academy of Neurology (EAN) 2026 in Geneva,...

Medscape Education

- PMLiVE

AbbVie to acquire Apogee Therapeutics in $10.9bn deal

The acquisition includes clinical-stage candidates for atopic dermatitis and asthma

- PMLiVE

Biogen to acquire RayThera in $1bn deal

The acquisition will expand the company’s immunology pipeline

Subscribe to our email news alerts

Latest content

Latest intelligence

Quick links